Table 1-.
Anthropometric characteristics, preoperative risk and preoperative laboratory data
| Control Group (n=55) | Treated Group (n=54) | |
|---|---|---|
| Male (%) | 56.9 | 43.1 |
| Age (years), mean (SD) | 58 (± 12) | 57 (± 12) |
| Weight (kg), mean (SD) | 68.7 (± 12.9) | 63.3 (± 11.2) |
| Height (cm), mean (SD) | 162.5 (± 8.4) | 162.1 (± 8.3) |
| BMI, mean (SD) | 26 (± 4.9) | 24 (± 3.4) |
| ASA (physical status) – P4 (%) | 86.3 | 70.2 |
| EuroSCORE®, mean(SD) | 3.5 (± 2.1) | 3.2 (± 2.2) |
| Canadian, mean(SD) | 3.0 (± 2.4) | 3.0 (± 2.3) |
| Parsonnet, mean(SD) | 11.1 (± 6.1) | 11.3 (± 7.0) |
| Glucose preop | 138.4 (± 74.6) | 113.4 (± 42.5) |
| Cholesterol | 220.8 (± 135.7) | 189.1 (± 42.3) |
| Triglycerides | 135.5 (± 62.4) | 122.7 (± 63.8) |
| Creatinine | 76.3 (± 18.9) | 72.1 (± 17.7) |
| Hematocrit - % | 40.9 (± 3.9) | 41.7 (± 4.5) |
*
P ≤ 0,05 value statistically significant
Obs: Glucose preop = glucose level preoperative, mg/dl; Cholesterol = total cholesterol, mg/dl; Triglycerides = mg/dl; Creatinine = creatinine clearance ml/min; P ≤ 0,05 value statistically significant